Answers are grounded in this paper and cite their sources.
Retrospective analysis shows arthroscopic debridement combined with PRP improves outcomes in ankle osteoarthritis, suggesting better efficacy than debridement alone.
Objective To assess the efficacy of arthroscopic debridement combined with platelet-rich plasma (PRP) therapy in treating advanced ankle osteoarthritis (OA). Design The data of 34 advanced ankle OA patients were retrospectively analyzed, with 17 patients undergoing arthroscopic debridement alone (No-PRP group) and 17 receiving debridement with PRP therapy (PRP group). The Self-Administered Foot Evaluation Questionnaire (SAFE-Q) was evaluated preoperatively and at 3, 6, and 12 months postoperatively. The complications were assessed throughout the follow-up period. Results In the PRP group, all SAFE-Q subscales significantly improved at 6- and 12-month post-treatment compared with baseline ( P < 0.05), whereas improvements in the No-PRP group were limited. For severe ankle OA patients, only the pain-related subscale of the SAFE-Q significantly improved from baseline in the No-PRP group ( P < 0.05). In contrast, all SAFE-Q subscales demonstrated significant improvement at 12 months postoperatively in the PRP group ( P < 0.05). The recurrence rates were 23.5% in the No-PRP group and 11.8% in the PRP group. Conclusion Arthroscopic debridement combined with PRP therapy for advanced ankle OA significantly improved all SAFE-Q subscales postoperatively, whereas debridement alone had limited benefits. This combination may offer an effective treatment for advanced ankle OA.
No takes yet. Share an insight, caveat, or question.
Miura et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: